Trials / Completed
CompletedNCT05141903
Dietary Supplement With and Without a Probiotic and/or Antibiotic
Dietary Study of a Complex Oligosaccharide With and Without a Probiotic Following Antibiotic Treatment in Healthy Volunteers
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 92 (actual)
- Sponsor
- Prolacta Bioscience · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- —
Summary
Complex oligosaccharides can alter the gut microbiome by aiding in the growth of certain organisms, and possibly, inhibiting others. The synergy with a probiotic may enhance gastrointestinal colonization.
Detailed description
The study will evaluate the synergy of the use of a complex oligosaccharide with and without a probiotic on the human microbiome in healthy volunteers who have received antibiotics. The combination should support general gastrointestinal health. This study is a multi-dose randomized cohort trial using 18 subjects per cohort for a total of 90 healthy adult volunteers ages 18-75.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Antibiotic | Vancomycin (250 mg/dose), Metronidazole (500 mg/dose) |
| DIETARY_SUPPLEMENT | HMO Concentrate | Concentrated milk fortifiers from donor human milk |
| DIETARY_SUPPLEMENT | Probiotic | B. infantis |
| DIETARY_SUPPLEMENT | Food Supplement | Synthetic powder containing 2'-fucosyllactose (2'-FL) and lactoneotetraose (LNnT) |
Timeline
- Start date
- 2021-09-21
- Primary completion
- 2022-05-23
- Completion
- 2022-06-09
- First posted
- 2021-12-02
- Last updated
- 2025-02-17
- Results posted
- 2025-02-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05141903. Inclusion in this directory is not an endorsement.